The biotech sector witnessed a see-saw performance in 2024. Though the year started on a positive note, those gains were ...

A few are even practically no-brainer picks for long-term investors. Here's why I think Vertex Pharmaceuticals (NASDAQ: VRTX) ...

Investing in biotech stocks usually isn't for the faint of heart. These stocks tend to be highly volatile because of the ...

The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and ...

Here are four drug and biotech stocks, ARQT, MESO, MNPR and KOD, which have more than doubled in 2024 with room for further growth in 2025.

Here's why I think Vertex Pharmaceuticals (NASDAQ: VRTX) is the ultimate biotech stock to buy with $500 right now. Many biotechnology companies don't have approved products on the market ...

CRISPR Therapeutics' approved medicine could benefit from government coverage in the U.S. This is a good sign for the biotech ...

The biotech industry has lagged the broader ... team just identified what they believe are the 10 best stocks for investors to buy now… and CRISPR Therapeutics wasn’t one of them.

And you won't need a boatload of cash to invest in a few of them. Here are three no-brainer biotech stocks to buy with $200 right now. Where to invest $1,000 right now? Our analyst team just ...